Clinical Trial Update: Effect of Rosuvastatin Therapy on HDL2 Level [Phase 4]

View source ↗

Summary

This clinical trial update assesses the effect of rosuvastatin therapy on HDL2 cholesterol levels in patients with hyperlipidemia and coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hyperlipidemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Hyperlipemia, Coronary Heart Disease | Phase 4 | Status: UNKNOWN